Concord Biotech soars on getting USFDA nod for Mycophenolate Mofetil for Oral Suspension

Mumbai, June 3 (Udaipur Kiran): Concord Biotech is currently trading at Rs. 1231.00, up by 64.20 points or 5.50% from its previous closing of Rs. 1166.80 on the BSE. The scrip opened at Rs. 1235.00 and has touched a high and low of Rs. 1264.45 and Rs. 1194.00 respectively. So far 126043 shares were traded […]